Location History:
- Hoor, SE (1999)
- Lund, SE (1997 - 2012)
Company Filing History:
Years Active: 1997-2012
Title: Lars-Erik Briggner: Innovator in Pharmaceutical Chemistry
Introduction
Lars-Erik Briggner is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions to the development of innovative treatments for various medical conditions. His work focuses on creating novel compounds that can improve patient outcomes.
Latest Patents
Lars-Erik Briggner holds a patent for the Tosylate Salt of a 5-Pyrazolyl-2-Pyridone Derivative, which is useful in the treatment of Chronic Obstructive Pulmonary Disease (COPD). The specific compound detailed in the patent is 6-Methyl-5-(I-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate. This patent includes processes for preparing the salt and its novel crystalline form, as well as pharmaceutical compositions that incorporate this form for therapeutic use.
Career Highlights
Throughout his career, Lars-Erik Briggner has focused on advancing pharmaceutical research. His innovative approaches have led to the development of compounds that address significant health challenges. Despite having no patents listed under his name, his contributions to the field are noteworthy.
Collaborations
Lars-Erik Briggner has collaborated with esteemed colleagues such as Marie-Lyne Alcaraz and Per Tomas Klingstedt. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Lars-Erik Briggner is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of COPD and other medical conditions. His innovative spirit and collaborative efforts continue to drive advancements in the field.